Week 12-14 Flashcards

1
Q

Beta-lactams: Mechanism of Action

A

Inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing peptidoglycan cross-linking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Beta-lactams: Classes

A

Include penicillins, cephalosporins, carbapenems, and monobactams.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Penicillin G: Use

A

Used parenterally for syphilis and streptococcal infections; not stable in stomach acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Penicillin V: Use

A

Oral form used for mild streptococcal infections due to acid stability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Amoxicillin: Use

A

Broad-spectrum oral penicillin used for otitis media, sinusitis, and respiratory tract infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ampicillin: Adverse Effects

A

May cause gastrointestinal upset due to incomplete absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Piperacillin-Tazobactam: Use

A

Extended-spectrum penicillin combination used for serious hospital-acquired and intra-abdominal infections, covers Pseudomonas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

1st Generation Cephalosporins: Use

A

Used for MSSA skin infections and surgical prophylaxis (e.g., cefazolin, cephalexin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2nd Generation Cephalosporins: Use

A

Effective for respiratory and intra-abdominal infections; active against H. influenzae and anaerobes (e.g., cefuroxime, cefoxitin).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

3rd Generation Cephalosporins: Use

A

Broad gram-negative activity; used for meningitis and pneumonia (e.g., ceftriaxone, ceftazidime).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

4th Generation Cephalosporins: Use

A

Effective against Pseudomonas and Enterobacteriaceae; used in febrile neutropenia (e.g., cefepime).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5th Generation Cephalosporins: Use

A

Active against MRSA and resistant gram-positive organisms (e.g., ceftaroline).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fluoroquinolones: Mechanism of Action

A

Inhibit DNA gyrase (gram-negative) and topoisomerase IV (gram-positive), blocking DNA replication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ciprofloxacin: Use

A

Effective against gram-negative infections including Pseudomonas; used for UTIs, GI infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Levofloxacin: Use

A

Improved gram-positive coverage; used for pneumonia, UTIs, skin infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Moxifloxacin: Use

A

Covers anaerobes and gram-positives; not used for UTIs due to low urinary concentration.

17
Q

Fluoroquinolones: Adverse Effects

A

Tendon rupture, CNS toxicity, QT prolongation, peripheral neuropathy, dysglycemia.

18
Q

Fluoroquinolones: Absorption Concern

A

Chelation with divalent/trivalent cations (e.g., calcium) reduces absorption.

19
Q

Tetracyclines: Mechanism of Action

A

Bind to 30S ribosomal subunit, blocking tRNA binding and inhibiting protein synthesis (bacteriostatic).

20
Q

Tetracyclines: Adverse Effects

A

Tooth discoloration, GI upset, hepatotoxicity, photosensitivity, intracranial hypertension, vestibular effects.

21
Q

Doxycycline: Use

A

Used for tick-borne diseases, respiratory infections, and in penicillin-allergic patients.

22
Q

Doxycycline: Elimination

A

Preferred in renal impairment due to fecal elimination.

23
Q

Aminoglycosides: Mechanism of Action

A

Bind to 30S subunit, causing misreading of mRNA and disrupting protein synthesis (bactericidal).

24
Q

Aminoglycosides: Use

A

Used for aerobic gram-negative bacilli; ineffective in anaerobic infections.

25
Aminoglycosides: Adverse Effects
Ototoxicity, nephrotoxicity, neuromuscular blockade.
26
Amikacin: Role
Reserved for resistant infections due to low susceptibility to enzymatic inactivation.
27
Macrolides: Mechanism of Action
Inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit (bacteriostatic).
28
Azithromycin: Use
Used for respiratory infections; once-daily dosing due to long half-life and high tissue penetration.
29
Macrolides: Adverse Effects
GI upset, cholestatic jaundice (erythromycin estolate), ototoxicity, QT prolongation.
30
TMP-SMX: Mechanism of Action
Inhibits folate synthesis by blocking dihydropteroate synthase (SMX) and dihydrofolate reductase (TMP).
31
TMP-SMX: Use
Effective against UTIs, MRSA skin infections, and Pneumocystis jirovecii.
32
TMP-SMX: Adverse Effects
Hyperkalemia, rash, Stevens-Johnson syndrome, hematologic effects.
33
Time-Dependent Killing
Effectiveness depends on duration drug concentration stays above MIC (e.g., beta-lactams).
34
Concentration-Dependent Killing
Higher peak concentrations increase effectiveness (e.g., aminoglycosides, fluoroquinolones).
35
Post-Antibiotic Effect
Antimicrobial activity persists after serum levels fall below MIC (e.g., aminoglycosides).